{"url_path":"/sec/achc/8-k/2026-05-18/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1520697/0001193125-26-229138-index.html","accession_number":"0001193125-26-229138","cik":"0001520697","ticker":"ACHC","issuer_name":"Acadia Healthcare Company, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1520697/0001193125-26-229138-index.html","primary_entity_key":"0001520697","primary_entity_name":"Acadia Healthcare Company, Inc."},"word_count":449,"has_tables":true,"body_markdown":"Item 8.01 Other Events.\n\nSan Diego Health Alliance, Inc. d/b/a Fashion Valley CTC (“Fashion Valley”), an indirect subsidiary of Acadia Healthcare Company, Inc. (the “Company”), is a defendant in an employment-related lawsuit filed in the Superior Court of San Diego County, California. Fashion Valley operates a comprehensive treatment center where a former employee who was terminated in October 2023 filed suit alleging retaliatory termination. Fashion Valley vehemently denied the allegations and asserted the plaintiff was terminated for legitimate reasons.\n\nThe case went to trial in late April 2026, and on May 12, 2026, a jury awarded the plaintiff compensatory damages of $35 million and punitive damages of $70 million. This award far exceeds any reasonable expectation based on precedent for comparable employment cases. The Company, which is not a party to the lawsuit, and Fashion Valley strongly disagree with the verdict and remain confident in Fashion Valley’s legal position based on the underlying facts of the case. Fashion Valley is evaluating all legal options and intends to vigorously challenge the verdict in post-trial motions and, if necessary, on appeal. We can make no assurances regarding the ultimate outcome of the case or whether the damages awarded by the jury will ultimately be reduced.\n\nCautionary Note Regarding Forward-Looking Statements\n\nThis Current Report on Form 8-K contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, including statements related to the defendants’ intent to challenge the verdict. These forward-looking statements are made only as of the date of this report. The Company does not undertake to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are based on current expectations and involve risks and uncertainties, and the final resolution of the case could differ significantly from those expressed or implied by the forward-looking statements.\n\nDescription of Business\n\nUnless the context otherwise requires, all references herein to “Acadia,” “the Company,” “we,” “us” or “our” mean Acadia Healthcare Company, Inc. and its consolidated subsidiaries. Acadia Healthcare Company, Inc. is a holding company whose direct and indirect subsidiaries own and operate acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers, residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the U.S. and Puerto Rico.\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDate: May 18, 2026\n \nACADIA HEALTHCARE COMPANY, INC.\n\n \n\n \nBy:\n \n\n/s/ Brian P. Farley\n\n \n\n \n\n \nBrian P. Farley\n\n \n\n \n\n \nExecutive Vice President, Chief Legal and Administrative Officer, and Secretary"}